Skip to content

Role of Vaman Dhauti (Kunjal Kriya) and Guduchyadikwath in the management of Amalpitta W.S.R.Hyperacidity

A Comparative Clinical Study to evaluate the effect of Vaman Dhauti (Kunjal Kriya) and Guduchyadikwath in the management of Amalpitta. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071846
Enrollment
100
Registered
2024-08-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis

Interventions

None listed

Sponsors

Dr Amanpreet Kaur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients ready to give written consent.Patients presenting with classical features of Amlapitta. Patients with chronicity of less than 3 years.

Exclusion criteria

Exclusion criteria: Patients not willing for the trial.Patients below age of 20 years and above 60 years of age.Patients using Aspirin or other NSAID’s Patients having any malignancy, history of gastric surgery, Cardiac problems, Tuberculosis, Diabetes Mellitus. Alarming symptoms like weight loss, GI bleeding and any other serious ailment.Patients having HIV, TB, or other grievous diseases.Any other patient considered unfit for inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Improvement in clinical features of amalpitta like HrithkanthaDaha ,Amlodgara ,Utklesha ,Avipaka ,Chhardi ,Aruchi,KukshiDaha,UdaradhmanaTimepoint: 0th day,1st week,2nd week, 3rd week, 4th week

Secondary

MeasureTime frame
Endoscopy will be done in case of Peptic ulcer.Timepoint: 0th day, 28th day.

Countries

India

Contacts

Public ContactNeerja Sharma

Dhanwantri Ayurvedic College

neerjasharma2966@gmail.com9041584513

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026